Physician profile
Kathryn R Frega
NPI 1790067783
$2,217.87
in general payments reported to CMS, 2019-2025
12 companies · $1,057 in 2025
The $1,057 reported for 2025 was more than what 97% of Chiropractor providers received nationally (typical 2025 total: $40.91).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $110 · 2022: $264 · 2023: $389 · 2024: $397 · 2025: $1,057.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,005 · Travel and Lodging: $839.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,004.60 |
| Travel and Lodging | $839.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Brainsway USA INC | $839.36 | 2025 | Deep Tms System |
| Abbvie INC. | $414.64 | 2021-2025 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $334.84 | 2023-2025 | Caplyta |
| Axsome Therapeutics, INC. | $257.49 | 2022-2025 | Auvelity |
| Idorsia Pharmaceuticals US INC | $89.14 | 2023-2024 | Quviviq |
| Ironshore Pharmaceuticals INC. | $65.00 | 2023-2024 | Jornay Pm |
| Tris Pharma INC | $57.17 | 2024-2025 | Dyanavel Xr |
| Supernus Pharmaceuticals, INC. | $42.57 | 2022 | |
| Janssen Pharmaceuticals, INC | $40.35 | 2025 | Spravato |
| Takeda Pharmaceuticals U.S.A., INC. | $35.99 | 2023 | Trintellix |
| Corium, LLC | $22.43 | 2024 | Azstarys |
| Otsuka America Pharmaceutical, INC. | $18.89 | 2024 | Rexulti |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kathryn Frega listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.